Medline INC. (MDLN) — SEC Filings
Latest SEC filings for Medline INC.. Recent ARS filing on Apr 23, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
View Medline INC. on SEC EDGAR
Overview
Medline INC. (MDLN) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a ARS filed on Apr 23, 2026: Medline Inc. filed its Annual Report to Security Holders (ARS) on April 23, 2026, for the period ending December 31, 2025. The report details the company's financial performance and operations for the fiscal year. Medline Inc. is involved in the Surgical & Medical Instruments & Apparatus industry.
Sentiment Summary
Across 6 filings, the sentiment breakdown is: 1 bullish, 3 neutral, 2 mixed. The dominant filing sentiment for Medline INC. is neutral.
Filing Type Overview
Medline INC. (MDLN) has filed 1 ARS, 1 DEFA14A, 1 8-K, 2 S-1/A, 1 S-1 with the SEC between Oct 2025 to Apr 2026.
Filings by Year
Recent Filings (6)
-
Medline Inc. Files Annual Report for FY 2025
— ARS · Apr 23, 2026 Risk: low
Medline Inc. filed its Annual Report to Security Holders (ARS) on April 23, 2026, for the period ending December 31, 2025. The report details the company's fina - DEFA14A Filing — DEFA14A · Apr 23, 2026
-
Medline Inc. Files 8-K: Material Agreements & Corporate Changes
— 8-K · Dec 22, 2025 Risk: medium
On December 16, 2025, Medline Inc. entered into a material definitive agreement. The company also reported on material modifications to the rights of security h -
Medline Targets Nasdaq Debut with 179M Share IPO
— S-1/A · Dec 8, 2025 Risk: medium
Medline Inc. is launching its initial public offering (IPO) of 179,000,000 shares of Class A common stock, with an expected price range of $26.00 to $30.00 per -
Medline Files S-1/A for IPO, Dual-Class Stock Structure Planned
— S-1/A · Nov 4, 2025 Risk: medium
Medline Inc. (MDLN) filed an S-1/A on November 4, 2025, for its initial public offering of Class A common stock, with an expected price range between $X and $Y -
Medline Files S-1 for Nasdaq IPO, Eyes Debt Paydown
— S-1 · Oct 28, 2025 Risk: medium
Medline Inc. (MDLN) has filed an S-1 for its initial public offering, aiming to list Class A common stock on the Nasdaq Global Select Market. The company will h
Risk Profile
Risk Assessment: Of MDLN's 5 recent filings, 0 were flagged as high-risk, 4 as medium-risk, and 1 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Key Executives
- James Boyle
- Alex Liberman
- Mills Family
Industry Context
Medline operates within the highly competitive medical supplies distribution industry, serving a broad range of healthcare providers. Key trends include consolidation among distributors and providers, increasing demand for cost-efficiency, and the growing importance of technology in supply chain management. The industry is also heavily influenced by healthcare policy and reimbursement rates.
Top Tags
IPO (3) · Dual-Class Stock (3) · Healthcare Supply Chain (2) · annual-report (1) · sec-filing (1) · medical-devices (1) · material-agreement (1) · corporate-governance (1) · officer-changes (1) · bylaws (1)
Key Numbers
- Period of Report: 2025-12-31 — The end date of the fiscal year covered by the report.
- Filing Date: 2026-04-23 — The date Medline Inc. submitted its ARS filing.
- SEC File Number: 001-43022 — Identifier for Medline Inc.'s filings
- IRS Employer Identification No.: 33-1845288 — Tax identification for Medline Inc.
- Shares of Class A common stock offered: 179,000,000 — Initial public offering quantity
- Low end of expected IPO price range per share: $26.00 — Expected initial public offering price
- High end of expected IPO price range per share: $30.00 — Expected initial public offering price
- Indicated interest from Mills Family: $250 million — Potential share purchase by existing owners
- Aggregate indicated interest from cornerstone investors: $2,350 million — Significant institutional demand for shares
- Additional shares underwriters option to purchase: 26,850,000 — Greenshoe option for Class A common stock
- Page number for Risk Factors: 32 — Location of detailed risk disclosures
- Filing date of S-1/A: 2025-12-08T00:00:00Z — Date of the latest amendment to the registration statement
- Lower end of initial public offering price range: $X — Expected IPO price per share of Class A common stock
- Upper end of initial public offering price range: $Y — Expected IPO price per share of Class A common stock
- Underwriters' option period: 30 days — Timeframe for underwriters to purchase additional shares
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Medline INC. (MDLN)?
Medline INC. has 6 recent SEC filings from Oct 2025 to Apr 2026, including 2 S-1/A, 1 ARS, 1 DEFA14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of MDLN filings?
Across 6 filings, the sentiment breakdown is: 1 bullish, 3 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Medline INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Medline INC. (MDLN) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Medline INC.?
Financial highlights for Medline INC. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for MDLN?
The investment thesis for MDLN includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Medline INC.?
Key executives identified across Medline INC.'s filings include James Boyle, Alex Liberman, Mills Family.
What are the main risk factors for Medline INC. stock?
Of MDLN's 5 assessed filings, 0 were flagged high-risk, 4 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Medline INC.?
Forward guidance and predictions for Medline INC. are extracted from SEC filings as they are enriched.